Khoom Taw Qhia
CAS Naj Npawb: 74150-27-9
Standard: Hauv tsev txheem
Pimobendan yog ib hom tshuaj siv los kho mob me, mob plawv lossis mob plawv tsis ua hauj lwm los ntawm atrioventricular insufficiency lossis myocardial hypertrophy hauv dev.
Daim ntawv thov
Pimobendan yog cov tshuaj uas tau siv los kho lub plawv tsis ua hauj lwm hauv cov dev txij li thaum nws pom zoo los ntawm FDA xyoo 2007, nws yog benzimidazole-pyridazinone derivative, sau npe rau kev siv rau cov dev los tswj lub plawv tsis ua hauj lwm (CHF) uas tshwm sim los ntawm dilated cardiomyopathy (DCM). ) lossis degenerative mitral valve disease (DMVD) hauv Tebchaws Meskas. Raws li nws cov txiaj ntsig zoo inotropic ua ke nrog arteriovenous dilation, nws raug cais raws li inodilator.
Pimobendan zoo li muaj kev nyab xeeb thiab zam tau zoo. Tshaj tawm cov teebmeem tshwm sim tsis tshua muaj thiab feem ntau txwv rau kev mob plab hnyuv uas cuam tshuam nrog cov ntsiav tshuaj chewable. Qhov tseem ceeb tshaj plaws tau tshaj tawm tias ua rau pimobendan toxicity, manifested li hnyav tachycardia thiab me me hloov nyob rau hauv cov ntshav siab.
Cim npe nrov: txheem pimobendan api 74150-27-9, Tuam Tshoj tus qauv pimobendan api 74150-27-9 manufacturers, lwm tus neeg, Hoobkas
